It will also be interesting to see whether and how differences in headline figures for weight loss delivered by different therapies translate into CV benefits and, especially, if this would give more potent therapies than Wegovy a competitive advantage
Absolutely a QME
[247] In April 2025, Eli Lilly, represented by Kirkland & Ellis and Walsh Pizzi O'Reilly Falanga, filed a series of lawsuits in federal courts in New Jersey and California against several telehealth and compounding pharmacy companies, including Willow Health Services, Henry Meds, Mochi Health, Fella Health, and Empower Clinic Services, alleging unfair competition, false advertising, and deceptive business practices related to the sale of unapproved compounded tirzepatide products marketed for weight loss
Here is how MEDvidi performs: Taken together, MEDvidi is reliable on safety and clarity, but the long-term structure and total cost place it squarely in the middle of our rankings